Clinical trial
Comparative Efficacy of Clobetasol 0.05% Versus Intralesional Triamcinolone in Treatment of Hypertrophic Lichen Planus at a Tertiary Care Hospital
NCT07666620 is registered in ClinicalTrials.gov with Noor Aziz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Efficacy of Clobetasol 0.05% Versus Intralesional Triamcinolone in Treatment of Hypertrophic Lichen Planus at a Tertiary Care Hospital
- Lead sponsor
- Noor Aziz
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- October 1, 2026
- Completion date
- April 30, 2027
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypertrophic lichen planus